棕榈酰化蛋白质组学分析揭示前列腺癌细胞中雄激素促进代谢相关蛋白棕榈酰化修饰

doi:10.19723/j.issn.1671-167X.2020.02.006

北京大学学报（医学版） ›› 2020, Vol. 52 ›› Issue (2): 227-233. doi: 10.19723/j.issn.1671-167X.2020.02.006

棕榈酰化蛋白质组学分析揭示前列腺癌细胞中雄激素促进代谢相关蛋白棕榈酰化修饰

李文卿¹,任思楣^2,^3,^△(),龙星博^3,⁴,田雨青¹

^1. 北京医院国家老年医学中心国家卫生健康委员会北京老年医学研究所国家卫生健康委员会北京老年医学重点实验室中国医学科学院老年医学研究院,北京 100730
^2. 北京医院国家老年医学中心国家卫生健康委员会临床检验中心中国医学科学院老年医学研究院,北京 100730
^3. 中国医学科学院北京协和医学院研究生院,北京 100730
^4. 北京医院泌尿外科,北京 100730

收稿日期:2019-12-10 出版日期:2020-04-18 发布日期:2020-04-18
通讯作者: 任思楣 E-mail:rensimei4162@bjhmoh.cn
基金资助:
国家自然科学基金(81670161);北京医院博士启动基金(BJ2015-105)

Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells

Wen-qing LI¹,Si-mei REN^2,^3,^△(),Xing-bo LONG^3,⁴,Yu-qing TIAN¹

^1. The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China
^2. National Center for Clinical Laboratory, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China
^3. Graduate School of Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China
^4. Department of Urology, Beijing Hospital, Beijing 100730, China

Received:2019-12-10 Online:2020-04-18 Published:2020-04-18
Contact: Si-mei REN E-mail:rensimei4162@bjhmoh.cn
Supported by:
Supported by the National Natural Science Foundation of China(81670161);Beijing Hospital Initial Foundation for Doctors(BJ2015-105)

摘要/Abstract

摘要：

目的筛选棕榈酰化修饰水平受雄激素诱导的蛋白,探索前列腺癌去雄激素治疗外其他潜在的治疗靶点.方法: 以LNCaP细胞为研究对象,雄激素(Methyltrienolone,R1881,5 nmol/L)或DMSO(dimethyl sulfoxide)处理LNCaP细胞24 h,同时利用人工合成的炔基棕榈酸Alk-C16 (100 μmol/L)对细胞进行代谢标记,收集细胞,裂解,提取总蛋白,加入标记有叠氮化物的琼脂糖珠 (1 mmol/L), 室温反应1 h,利用叠氮化物与Alk-C16末端炔基发生点击化学反应形成的共价键将棕榈酰化修饰蛋白富集在琼脂糖珠上,进行蛋白质谱非标记定量分析(label-free quantitation, LFQ), 比较R1881处理和非处理细胞蛋白棕榈酰化修饰变化情况,筛选棕榈酰化修饰水平受雄激素诱导的蛋白.结果: 实验共鉴定出907个潜在的棕榈酰化修饰蛋白(mascot score> 2, P<0.05), 其中有430个蛋白LFQ值至少有2次不为0.在这430个蛋白中有92个蛋白R1881处理与非处理样品LFQ比值大于 1.5(P<0.05), 说明雄激素能够显著促进该蛋白棕榈酰化修饰.利用Cytoscape软件对92个蛋白进行功能富集分类,发现已知功能蛋白可分为代谢相关,蛋白折叠相关和翻译起始相关3类,其中,代谢相关蛋白包括脂代谢(6个),糖代谢(7个)和呼吸电子传递链(8个)3部分,另外还有少量氨基酸代谢(2个)和其他代谢相关蛋白(2个).参与呼吸电子传递链的细胞色素b-c1复合体亚基2 (cytochrome b-cl complex subunit2, UQCRC2) 雄激素R1881处理和未处理样品LFQ比值最高(>3,P<0.05),说明该蛋白棕榈酰化修饰受雄激素诱导最为明显.LFQ比值最高为UQCRC2,其次为脂代谢相关的长链特异性酰基辅酶A脱氢酶(very long-chain specific acyl-CoA dehydrogenase, ACADVL)和糖代谢相关的6-磷酸葡萄糖酸脱氢酶(6-phosphogluconate dehydrogenase, PGD), 但其LFQ比值均未超过3.结论: 代谢尤其是呼吸电子传递链相关蛋白的棕榈酰化调控机制的研究可能将为前列腺癌的诊疗和靶向药的研发提供新的指导思路.

关键词: 前列腺癌, 雄激素, 棕榈酰化, 代谢

Abstract:

Objective: To explore potential therapeutic targets other than androgen-deprivation treatment for prostate cancer by screening the proteins induced by androgen at palmitoylation modification level in LNCaP cells.Methods: The LNCaP cells were treated with androgen (Methyltrienolone, R1881, 5 nmol/L) or dimethyl sulfoxide (DMSO) for 24 h, and then labeled with alkynyl palmitic acid Alk-C16 (100 μmol/L). After that, the cells were collected, lysed, the total protein was extracted, agarose beads labeled with azide (1 mmol/L) were added, and the click-chemistry reaction was carried out at room temperature for 1 h. The covalent bond formed by click-chemistry reaction of azide and alkynyl group was used to enrich the palmitoylated proteins on agarose beads. Label-free quantitation (LFQ) was used to compare the protein palmitoylation level of R1881 treated and untreated cells to screen the proteins induced by androgen at palmitoylation modification level.Results: In this experiment, 907 potential palmitoylated proteins (mascot score>2, P<0.05) were identified, among which 430 proteins had LFQ values not zero at least twice. Among the 430 proteins, the palmitoylation levels of 92 candidates were increased by androgen treatment, and their LFQ values were significantly upregulated (>1.5-fold, P<0.05) in ≥2 samples of androgen-treated vs. untreated LNCaP cells. We also used the software of cytoscape to classify the 92 proteins, and found that the known functional proteins of them could be divided into three categories: metabolism related, protein folding related and translation initiation related. Among them, metabolism related proteins included lipid metabolism (6), glucose metabolism (7) and respiratory electron transport chain (8), and a small amount of amino acid metabolism (2) and other metabolism related proteins (2). Notably, the ratio of LFQ of cytochrome b-c1 complex subunit 2 (UQCRC2) was significantly (>3-fold, P<0.05) higher in androgen-treated cells compared with untreated cells, indicating that the palmitoylation level of UQCRC2 was enhanced by androgen most significantly than that of others. The second was long-chain acyl CoA dehydrogenase (ACADVL) related to lipid metabolism and glucose 6-phosphate dehydrogenase (PGD) related to glucose metabolism, but the LFQ ratio of them was less than 3-fold.Conclusion: The research on palmitoylation mechanism of metabolism, especially the proteins related to respiratory electron transport chain, will provide a new guidance for the diagnosis and treatment of prostate cancer and the development of targeted drugs.

Key words: Prostate cancer, Androgen, Palmitoylation, Metabolism

中图分类号:

R737.25

李文卿,任思楣,龙星博,田雨青. 棕榈酰化蛋白质组学分析揭示前列腺癌细胞中雄激素促进代谢相关蛋白棕榈酰化修饰[J]. 北京大学学报（医学版）, 2020, 52(2): 227-233.

Wen-qing LI,Si-mei REN,Xing-bo LONG,Yu-qing TIAN. Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells[J]. Journal of Peking University (Health Sciences), 2020, 52(2): 227-233.

图/表 4

图1

图2

图3

图4

参考文献 27

[1]	Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424.
[2]	Chen W, Zheng R, Zhang S , et al. Cancer incidence and mortality in China, 2013[J]. Cancer Lett, 2017,401:63-71.
[3]	Watson PA, Arora VK, Sawyers CL . Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer[J]. Nat Rev Cancer, 2015,15(12):701-711.
[4]	Wyatt AW, Gleave ME . Targeting the adaptive molecular landscape of castration-resistant prostate cancer[J]. EMBO Mol Med, 2015,7(7):878-894.
[5]	Bishop JL, Davies A, Ketola K , et al. Regulation of tumor cell plasticity by the androgen receptor in prostate cancer[J]. Endocr Relat Cancer, 2015,22(3):R165-182.
[6]	Quigley DA, Dang HX, Zhao SG , et al. Genomic hallmarks and structural variation in metastatic prostate cancer[J]. Cell, 2018,175(3):889.
[7]	Viswanathan SR, Ha G, Hoff AM , et al. Structural alterations driving castration-resistant prostate cancer revealed by linked-read genome sequencing[J]. Cell, 2018,174(2):433-447.e419.
[8]	Aicart-Ramos C, Valero RA, Rodriguez-Crespo I . Protein palmitoylation and subcellular trafficking[J]. Biochim Biophys Acta, 2011,1808(12):2981-2994.
[9]	Charollais J , Van Der Goot FG. Palmitoylation of membrane proteins[J]. Mol Membr Biol, 2009,26(1):55-66.
[10]	Ko PJ, Dixon SJ . Protein palmitoylation and cancer[J]. EMBO Rep, 2018,19(10):e46666.
[11]	Thinon E, Hang HC . Chemical reporters for exploring protein acylation[J]. Biochem Soc Trans, 2015,43(2):253-261.
[12]	Gottlieb CD, Linder ME . Structure and function of DHHC protein S-acyltransferases[J]. Biochem Soc Trans, 2017,45(4):923-928.
[13]	Pepinsky RB, Zeng C, Wen D , et al. Identification of a palmitic acid-modified form of human sonic hedgehog[J]. J Biol Chem, 1998,273(22):14037-14045.
[14]	Chen S, Zhu B, Yin C , et al. Palmitoylation-dependent activation of MC1R prevents melanomagenesis[J]. Nature, 2017,549(7672):399-403.
[15]	Yao H, Lan J, Li C , et al. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours[J]. Nat Biomed Eng, 2019,3(4):306-317.
[16]	Hannoush RN, Sun J . The chemical toolbox for monitoring protein fatty acylation and prenylation[J]. Nat Chem Biol, 2010,6(7):498-506.
[17]	Hernandez JL, Davda D, Majmudar JD , et al. Correlated S-palmitoylation profiling of snail-induced epithelial to mesenchymal transition[J]. Mol Biosyst, 2016,12(6):1799-1808.
[18]	Hannoush RN, Arenas-Ramirez N . Imaging the lipidome: omega-alkynyl fatty acids for detection and cellular visualization of lipid-modified proteins[J]. ACS Chem Biol, 2009,4(7):581-587.
[19]	Liu NQ, Braakman RB, Stingl C , et al. Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue[J]. J Mammary Gland Biol Neoplasia, 2012,17(2):155-164.
[20]	Li W, Li W, Zou L , et al. Membrane targeting of inhibitory Smads through palmitoylation controls TGF-beta/BMP signaling[J]. Proc Natl Acad Sci USA, 2017,114(50):13206-13211.
[21]	Liberti MV, Locasale JW . The Warburg effect: how does it benefit cancer cells[J]. Trends Biochem Sci, 2016,41(3):287.
[22]	Li C, Zhang G, Zhao L , et al. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer[J]. World J Surg Oncol, 2016,14(1):15.
[23]	Warburg O . On the origin of cancer cells[J]. Science, 1956,123(3191):309-314.
[24]	Koppenol W, Bounds P . The Warburg effect and metabolic efficiency: recrunching the numbers[J]. Science, 2009,324:1029-1033.
[25]	Shen LF, Chen YJ, Liu KM , et al. Role of S-palmitoylation by ZDHHC13 in mitochondrial function and metabolism in liver[J]. Sci Rep, 2017,7(1):2182.
[26]	Crofts AR, Hong S, Wilson C , et al. The mechanism of ubihydroquinone oxidation at the Qo-site of the cytochrome bc1 complex[J]. Biochim Biophys Acta, 2013,1827(11/12):1362-1377.
[27]	王福 . 基于细胞色素bc1复合物三维结构的新型Q0位点抑制剂的设计与合成[D]. 华中师范大学, 2012.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

棕榈酰化蛋白质组学分析揭示前列腺癌细胞中雄激素促进代谢相关蛋白棕榈酰化修饰

Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells

RICH HTML

PDF (PC)

摘要/Abstract

引用本文

使用本文

图/表 4

参考文献 27

相关文章 15

Metrics

本文评价

推荐阅读 10

[1]	白杲琛,宋毅,金杰,虞巍,何志嵩. 多西他赛联合卡铂治疗转移性去势抵抗性前列腺癌的临床疗效[J]. 北京大学学报（医学版）, 2021, 53(4): 686-691.
[2]	徐涛,韩敬丽,姚伟娟. 雄激素剥夺治疗相关心血管疾病的机制与临床对策[J]. 北京大学学报（医学版）, 2020, 52(4): 607-609.
[3]	韩硕,陈章健,周迪,郑湃,张家赫,贾光. 纳米二氧化钛经口暴露90天对大鼠粪便代谢组的影响[J]. 北京大学学报（医学版）, 2020, 52(3): 457-463.
[4]	孙奎霞,闫存玲,李志艳,刘平,张伟,何群. 前列腺特异性抗原同源异构体2及其衍生指标在预测前列腺癌病理分级中的价值[J]. 北京大学学报（医学版）, 2020, 52(2): 234-239.
[5]	张勇,刘畅,陈彬,陈帆,段晋瑜,张孟钧,焦剑. 糖尿病前期患者糖代谢异常与慢性牙周炎的相关性[J]. 北京大学学报（医学版）, 2020, 52(1): 71-76.
[6]	张宽根,周雨禾,邵雅昆,梅放,由江峰,刘北英,裴斐. 肿瘤转移抑制基因LASS2/TMSG1 S248A突变体通过增加ATP6V0C表达促进前列腺癌的侵袭[J]. 北京大学学报（医学版）, 2019, 51(2): 210-220.
[7]	肖榆冰,郭慕瑶,左晓霞. 免疫代谢与系统性红斑狼疮[J]. 北京大学学报（医学版）, 2018, 50(6): 1120-1124.
[8]	唐旭，赵卫红，宋琴琴，殷华奇，杜依青，盛正祚，王强，张晓威，李清，刘士军，徐涛. SOX10对前列腺癌细胞增殖及侵袭的影响[J]. 北京大学学报(医学版), 2018, 50(4): 602-606.
[9]	邹鹏程,杨一峰,徐晓艳,刘北英,梅放,由江峰，刘启忱，裴斐 . 沉默液泡型ATP酶c亚基ATP6V0C抑制人前列腺癌细胞侵袭的分子机制[J]. 北京大学学报(医学版), 2017, 49(6): 937-947.
[10]	巩艳青，张崔建，何世明，李学松，周利群，郭应禄. 核转出蛋白对前列腺癌雄激素受体稳定性的调节[J]. 北京大学学报(医学版), 2017, 49(4): 569-574.
[11]	纪光杰，黄聪，宋刚，李学松，宋毅，周利群. 去势抵抗性前列腺癌进展时间的预测因素分析[J]. 北京大学学报(医学版), 2017, 49(4): 657-662.
[12]	花克涵，杨磊，张晓威，白文俊，李清，徐涛. 完全性雄激素不敏感综合征合并膀胱瘘1例报道及文献回顾[J]. 北京大学学报(医学版), 2017, 49(4): 724-729.
[13]	何柳，唐迅，胡永华. 绝经与心血管疾病及相关代谢紊乱的关联[J]. 北京大学学报(医学版), 2016, 48(3): 448-453.
[14]	杨恺惟, 虞巍, 宋毅, 黄立华, 韩文科, 何志嵩, 金杰, 周利群. 影响多西他赛联合泼尼松治疗转移性去势抵抗性前列腺癌疗效的因素分析[J]. 北京大学学报(医学版), 2015, 47(4): 592-596.
[15]	徐涛, 王晓峰. 前列腺癌治疗的“范式转变”——雄激素剥夺治疗应关注心血管的损害[J]. 北京大学学报（医学版）, 2014, 46(4): 501-503.